Rizvi Syed Ali-aamir 4
4 · Poseida Therapeutics, Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Rizvi Syed Ali-aamir
Chief Medical Officer
Transactions
- Award
Common Stock
2024-04-01+185,000→ 185,000 total - Award
Employee Stock Option (Right to Buy)
2024-04-01+250,000→ 250,000 totalExercise: $3.10Exp: 2034-03-31→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's 2022 Inducement Plan. The RSUs are scheduled to vest in four equal annual installments.
- [F2]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date, and the remaining shares will vest in 42 equal monthly installments thereafter.